• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drugs

  • Print
  • Share
  • E-mail

Crizotinib

Pharmacogenomic Information
  

Drug Link
in Drugs@FDA
Therapeutic AreaHUGO
Symbol
Referenced
Subgroup
Labeling Sections with
Pharmacogenomic
Information
CrizotinibOncologyALKALK gene
rearrangement positive
Indications and Usage
Dosage and Administration
Drug Interactions
Warnings and Precautions
Adverse Reactions
Clinical Pharmacology
Clinical Studies

 

back to Pharmacogenomic Biomarkers in Drug Labeling